Why the study?
Do circulating biomarkers of collagen synthesis accurately reflect myocardial collagen content in patients with hypertrophic cardiomyopathy?
Do circulating biomarkers of collagen synthesis accurately reflect myocardial collagen content in patients with hypertrophic cardiomyopathy?
Peripheral circulating biomarkers of collagen synthesis are not useful for estimating myocardial collagen content in patients with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Caution against relying on peripheral collagen biomarkers for myocardial fibrosis in HCM; leaves open need for direct tissue assessment.
The cardiac contribution to peripheral levels of byproducts of collagen synthesis in patients with HCM is insignificant. Furthermore, peripheral levels of these biomarkers do not accurately reflect myocardial collagen content in these patients.
No takes yet. Share an insight, caveat, or question.
Ellims et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: